Department of Emergency Medicine, Dr. P Phillips Hospital, Orlando Health, Orlando, FL; Residency in Emergency Medicine, Orlando Health, Orlando, FL; Florida State University College of Medicine, Tallahassee, FL.
Department of Emergency Medicine, Orlando Regional Medical Center, Orlando Health, Orlando, FL; Residency in Emergency Medicine, Orlando Health, Orlando, FL.
Ann Emerg Med. 2020 Oct;76(4):427-441. doi: 10.1016/j.annemergmed.2020.04.042. Epub 2020 Jun 25.
Debate exists about the mortality benefit of administering antibiotics within either 1 or 3 hours of sepsis onset. We performed this meta-analysis to analyze the effect of immediate (0 to 1 hour after onset) versus early (1 to 3 hours after onset) antibiotics on mortality in patients with severe sepsis or septic shock.
This review was consistent with the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. Searched databases included PubMed, EMBASE, Web of Science, and Cochrane Library, as well as gray literature. Included studies were conducted with consecutive adults with severe sepsis or septic shock who received antibiotics within each period and provided mortality data. Data were extracted by 2 independent reviewers and pooled with random effects. Two authors independently assessed quality of evidence across all studies with Cochrane's Grading of Recommendations Assessment, Development and Evaluation methodology and risk of bias within each study, using the Newcastle-Ottawa Scale.
Thirteen studies were included: 5 prospective longitudinal and 8 retrospective cohort ones. Three studies (23%) had a high risk of bias (Newcastle-Ottawa Scale). Overall, quality of evidence across all studies (Grading of Recommendations Assessment, Development and Evaluation) was low. Pooling of data (33,863 subjects) showed no difference in mortality between patients receiving antibiotics in immediate versus early periods (odds ratio 1.09; 95% confidence interval 0.98 to 1.21). Analysis of severe sepsis studies (8,595 subjects) found higher mortality in immediate versus early periods (odds ratio 1.29; 95% confidence interval 1.09 to 1.53).
We found no difference in mortality between immediate and early antibiotics across all patients. Although the quality of evidence across studies was low, these findings do not support a mortality benefit for immediate compared with early antibiotics across all patients with sepsis.
关于在脓毒症发作后 1 小时内或 3 小时内给予抗生素的死亡率获益,存在争议。我们进行了这项荟萃分析,以分析在严重脓毒症或感染性休克患者中,立即(发病后 0 至 1 小时内)与早期(发病后 1 至 3 小时内)使用抗生素对死亡率的影响。
本综述符合系统评价和荟萃分析的首选报告项目的准则。搜索的数据库包括 PubMed、EMBASE、Web of Science 和 Cochrane Library,以及灰色文献。纳入的研究是针对连续的患有严重脓毒症或感染性休克的成年人进行的,他们在每个时期内接受了抗生素治疗,并提供了死亡率数据。数据由 2 名独立评审员提取,并使用随机效应进行汇总。两名作者使用 Cochrane 的推荐评估、制定和评估方法对所有研究进行了独立评估,并使用纽卡斯尔-渥太华量表(Newcastle-Ottawa Scale)对每项研究的风险进行了评估。
纳入了 13 项研究:5 项前瞻性纵向研究和 8 项回顾性队列研究。有 3 项研究(23%)存在高偏倚风险(纽卡斯尔-渥太华量表)。总体而言,所有研究的证据质量(推荐评估、制定和评估)都较低。对数据进行汇总(33863 例患者)显示,在立即和早期使用抗生素的患者之间,死亡率没有差异(优势比 1.09;95%置信区间 0.98 至 1.21)。对严重脓毒症研究(8595 例患者)的分析发现,立即治疗组的死亡率高于早期治疗组(优势比 1.29;95%置信区间 1.09 至 1.53)。
我们发现所有患者的立即和早期抗生素治疗之间的死亡率没有差异。尽管研究证据的质量较低,但这些发现并不支持在所有脓毒症患者中,立即使用抗生素与早期使用相比具有死亡率获益。